Fuelling the ventures that will reshape global healthcare
Why we exist
Synthesis Capital exists to address a structural gap in the market: world-class health and medtech innovation across the Asia-Pacific region, yet too little specialist capital and company-building support to help the best ventures scale globally.
What we do
We back leading Asia-Pacific healthcare startups early. From pre-seed to Series A+, we invest where technical breakthroughs begin and where capital can have the
greatest impact.
We deploy staged capital aligned to milestones, supporting companies as they navigate technical, regulatory and commercial risk.
The Synthesis Capital model addresses critical funding gaps and supports companies at key inflection points as they scale.
A thesis of inclusive flourishing
A different kind of venture model
Through our partnership with the MedTech Actuator, Synthesis Capital investments are powered by one of the Asia-Pacific's most established healthtech commercialisation ecosystems.
This integration allows us to engage earlier and invest with greater conviction, supporting companies through key inflection points of growth. It provides a structured pathway for developing and scaling healthcare ventures, with access to regional markets, expertise and networks.
By combining capital with active risk management and milestone-based scaling, we have built an investment model designed for success and for the realities of healthcare innovation.
Our Team
Empowering ventures. Transforming lives.
Meet the team behind Synthesis Capital.
Financial returns through health impact
Great healthtech companies do not choose between commercial rigour and meaningful impact.
They are built on both.
Commercial discipline
The milestones, decisions and pathways that move ventures toward market readiness and long-term commercial success.
Health impact
A clear focus on the needs, behaviours and systems that solutions are designed to improve, and the lives they can change.
Synthesis Capital connects both. Through our ecosystem of capital, partners and expertise, we support exceptional ventures to become companies that shape the future of health, and deliver returns that demonstrate impact and investment can be mutually reinforcing..
FOR FOUNDERS
Supercharge your commercialisation journey
If you are building in health, we want to
hear from you.
We back founders developing deep healthtech innovations with the potential to deliver largescale impact.
Our focus is on deep technology, where success depends on navigating scientific, regulatory and commercial complexity.
We partner with teams with grit and who can benefit from access to a global network of expertise, insight and support.
Synthesis Capital is more than an investor. We are a long-term partner, working alongside founders as they translate innovation into real-world solutions and scale.
We don't just fund startups. We back the next generation of world-leading healthtech founders.
FOR INVESTORS
Investing in tomorrow's health innovations, today
Synthesis Capital invites investors to participate in this next phase of health innovation.
We invest in health technologies with the potential to reshape healthcare systems, focusing on opportunities where early-stage capital and disciplined execution can drive meaningful growth.
We invest across the Asia-Pacific, leveraging strong regional fundamentals and global exit potential.
Investment structures are designed to be tax-efficient, with potential eligibility for ESVCLP-related incentives (subject to investor circumstances and regulatory approval).
At Synthesis Capital, returns are driven by turning health innovation into real-world outcomes, aligning commercial success with measurable impact in global markets with real room to scale.